Viewing Study NCT05971758


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2025-12-25 @ 10:22 PM
Study NCT ID: NCT05971758
Status: RECRUITING
Last Update Posted: 2025-07-04
First Post: 2023-07-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Sponsor: University of California, Los Angeles
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module